Trial Profile

A Long-Term Open-Label Safety Study of Hydrocodone Bitartrate Controlled-Release Capsules With Flexible Dosing to Treat Subjects With Moderate to Severe Chronic Pain.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hydrocodone (Primary)
Indications Pain
Focus Adverse reactions; Registrational
Sponsors Zogenix

Most Recent Events

21 May 2013 An NDA submitted in March 2013 is anticipated to be reviewed by the FDA in the second half of 2013, according to the Q1 2013 financial report released by Zogenix.
07 Dec 2012 Results from this trial were included in a NDA submitted to the US FDA.
30 Sep 2011 The results are being analysed and will be submitted to the US FDA in early 2012, according to a Zogenix media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com